KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$9.93
+0.36 (+3.76%)
Open$9.67
Previous Close$9.57
Day High$9.98
Day Low$9.55
52W High$12.49
52W Low$5.45
Volume—
Avg Volume1.82M
Market Cap881.53M
P/E Ratio—
EPS$-3.35
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+362.4% upside
Current
$9.93
$9.93
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 74.97M | 146.41M | 142.51M |
| Net Income | -309,597,056 | 21.31M | 25.50M |
| Profit Margin | -413.0% | 14.6% | 17.9% |
| EBITDA | -336,179,310 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.06 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $243.73 | +3.76% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $356.32 | +1.39% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.43 | -0.58% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $484.49 | +1.96% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $625.11 | +0.27% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $291.90 | -0.73% | 64.3 | 37.13B |